102000-55-5 Usage
Uses
Used in Pharmaceutical Industry:
Pyridine, 2-amino-4-vinyl(6CI) is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, Pyridine, 2-amino-4-vinyl(6CI) is utilized in the production of pesticides and other agrochemicals. Its ability to form stable complexes with metal ions makes it a valuable component in the development of effective and environmentally friendly products.
Used in Organic Compounds Synthesis:
Pyridine, 2-amino-4-vinyl(6CI) is used as a building block in the synthesis of a wide range of organic compounds. Its reactivity and functional groups enable the creation of diverse molecules with various applications in the chemical industry.
Used as a Ligand in Coordination Chemistry:
Pyridine, 2-amino-4-vinyl(6CI) serves as a ligand in coordination chemistry, where it forms stable complexes with metal ions. These metal complexes have potential applications in catalysis, materials science, and other areas of research.
Overall, Pyridine, 2-amino-4-vinyl(6CI) is a significant compound in the chemical industry and research, with its applications spanning across multiple fields, including pharmaceuticals, agrochemicals, organic synthesis, and coordination chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 102000-55-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,0,0 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 102000-55:
(8*1)+(7*0)+(6*2)+(5*0)+(4*0)+(3*0)+(2*5)+(1*5)=35
35 % 10 = 5
So 102000-55-5 is a valid CAS Registry Number.
102000-55-5Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND USE THEREOF AS MODULATORS OF TYPE III RECEPTOR TYROSINE KINASES
-
Paragraph 0632; 0633; 1079, (2016/08/03)
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
INHIBITORS OF BRUTON'S TYROSINE KINASE
-
Paragraph 00469, (2015/04/15)
Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. In addition, reversible inhibitors of Btk are also described. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
